TDC
INCY icon

Thompson Davis & Co’s Incyte INCY Stock Holding History

Thompson Davis & Co’s Portfolio INCY Stock Details INCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-237
Closed -$28K – 870
2017
Q3 		$28K Buy
237
+26
+12% +$3.29K 0.05% 369
2017
Q2 		$27K Buy
211
+3
+1% +$382 0.04% 362
2017
Q1 		$28K Sell
208
-25
-11% -$3.18K 0.04% 378
2016
Q4 		$23K Hold
233
– – 0.04% 449
2016
Q3 		$22K Buy
233
+77
+49% +$6.49K 0.04% 436
2016
Q2 		$12K Hold
156
– – 0.02% 593
2016
Q1 		$11K Sell
156
-87
-36% -$6.48K 0.02% 627
2015
Q4 		$26K Buy
243
+87
+56% +$9.7K 0.04% 386
2015
Q3 		$17K Buy
+156
New +$17.5K 0.02% 513
2014
Q4 		– Sell
-250
Closed -$12K – 1205
2014
Q3 		$12K Sell
250
-125
-33% -$6.27K 0.02% 633
2014
Q2 		$21K Sell
375
-250
-40% -$12.8K 0.03% 385
2014
Q1 		$33K Buy
625
+125
+25% +$7.76K 0.05% 313
2013
Q4 		$25K Buy
+500
New +$21.8K 0.04% 319

Other funds holding INCY

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Thompson Davis & Co's INCY Position: Q4 2017 in Review

Thompson Davis & Co sold out of Incyte (INCY) in Q4 2017, closing a stake of 237 shares — an estimated $28K sold.

Thompson Davis & Co first reported a position in INCY in Q4 2013 and held it in 13 quarters. The position peaked at $33K in Q1 2014. 503 funds tracked by Wall St. Rank hold INCY as of Q4 2017.

  • Thompson Davis & Co reported no remaining Incyte position as of Q4 2017 after selling out during the quarter.
  • Thompson Davis & Co sold 237 Incyte shares in Q4 2017, an estimated $28K.
  • Thompson Davis & Co first reported a position in Incyte in Q4 2013 and held it in 13 quarters.
  • Thompson Davis & Co's Incyte position peaked at $33K in Q1 2014.
  • 503 funds tracked by Wall St. Rank held Incyte as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.